Abstract
1.Current UK guidelines for monitoring type 2 diabetes, chronic kidney disease and hypertension are largely based on expert opinion; robust evidence for optimal monitoring strategies and testing intervals is lacking.
2.Unnecessary testing in primary care can lead to false positives and false negatives, increase workload for clinicians, and increase costs for the health service.
3.Patients and healthcare professionals should be aware of these uncertainties, when making shared decisions about chronic disease monitoring.
2.Unnecessary testing in primary care can lead to false positives and false negatives, increase workload for clinicians, and increase costs for the health service.
3.Patients and healthcare professionals should be aware of these uncertainties, when making shared decisions about chronic disease monitoring.
| Original language | English |
|---|---|
| Article number | l2319 |
| Number of pages | 7 |
| Journal | BMJ |
| Volume | 365 |
| DOIs | |
| Publication status | Published - 13 Jun 2019 |
Access to Document
- Full-text PDF (accepted author manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via BMJ at https://www.bmj.com/content/365/bmj.l2319 Please refer to any applicable terms of use of the publisher.